Interactieve versie
U vindt veel meer informatie per bedrijf en veel meer bedrijven. Ook kunt u filters toepassen en exporteren naar Excel.
Bekijken
Amylyx Pharmaceuticals EMEA B.V.
Amsterdam - Noord-Holland
www.amylyx.com
Naam
Amylyx Pharmaceuticals EMEA B.V.
Website
www.amylyx.com
Sector
Natuurwetenschappelijk onderzoek en experimentele ontwikkeling
Werkenden
5-9 wn.
Adres
Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.
Postcode
1083HN
Plaatsnaam
Amsterdam
-16 00 03 06 08 1 13 16 2026 23 3 6 8 a a.m about accept accomplish action advanc agnostic agree all allow alongsid amlx amx0114 amylyx an analyz and announced announces annual anticipated are as assembled assist at audacious audio august avexitid bariatric based be becaus behalf betwen biomarker blind by call can car carer caring carry cash center challenges chart chicago chos clear clicking clinical cod commitment communities community company completed complianc condition conduct conferenc connection consumer contact cookie cookies corporat counting created critical cultur cur dat data decision defined deliver develop devic diseases dos dose-rang doubl double-blind driv e each early email encal endo endocrin enhanc era european experienc experienced families final financial find first first-in-human for foundation from greatest guidelines has hav health held her high history hom host human hypoglycemia il impact inc individual information insight integrity investigational investor it its join jun just know last lat latest learn legacies list living loved lucidity lumina mak management market matched mechanistic media medicin meeting mission modality mor nasdaq navigation ned network new next not notic novel now obstacles on ones open opportunities or organization other our out outcomes participant path pbh peopl period personal perspectiv pharmaceutical phas pipelin pivotal plac possibl post post-bariatric poster preclinical present presentation privacy promis purchas quarter question ranging rational read ready report reserved responsibility result right rigor rigorous rooted ru s scienc second see senior september serious serv services ses set setting similar sit social society solution som specific sped stay storing study subscrib supplier support system tak taking talented team technologies term territories than that the their therapies they this thursday to today toplin toughest track treating trial two types unmet up upcom updates urgency us usag use uses u
Vind meer informatie over Amylyx Pharmaceuticals EMEA B.V. in de interactieve versie